在孕产妇健康中推进铁疗法:发展治疗缺铁性贫血的策略
Sandesh Kamdi1, Priti Kumar2, Nishu Gupta3
1Postdoctoral Fellow, University of Maryland, Baltimore, MD.
Obstetrical & gynecological survey
|December 11, 2025
概括
怀孕期间缺铁性贫血 (IDA) 仍然是一个全球性的挑战,尽管治疗方面取得了进展. 目前的铁配方缺乏最佳的疗效和安全性,需要改进管理策略.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 营养科学 营养科学
背景情况:
- 缺铁性贫血 (IDA) 影响全球近三分之一的孕妇.
- 国际开发署对孕产妇和胎儿的不良结果做出了重大贡献,包括早产和低出生体重.
- 尽管铁疗法取得了进展,但IDA的患病率仍然很高,这强调了需要更好的管理.
研究的目的:
- 综合审查铁的吸收机制,当前的铁疗法指南,以及各种铁盐的疗效/安全性.
- 加强补充策略,以有效管理怀孕期间的IDA.
- 为医疗保健提供者提供用于诊断IDA和选择最佳铁配方的知识.
主要方法:
- 关于肠道铁吸收和胎盘运输机制的文献综述.
- 对口服和静脉注射铁的国际指南的分析.
- 评估不同铁配方的临床疗效和安全性.
主要成果:
- 铁的吸收和运输是复杂的,受到母亲/胎儿储存和肝素的影响.
- 没有任何一种铁配方是怀孕期间IDA管理的理想选择.
- 临床试验显示有效性和安全性是可变的,这表明治疗缺口.
结论:
- 在怀孕期间IDA的最佳铁疗法尚未实现.
- 进一步了解铁的吸收对于开发更有效的补充方法至关重要.
- 解决怀孕期间国际援助的全球负担需要改进管理策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Peritoneal Dialysis III: Nursing Management
592
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
592
Venous Thrombosis IV: Nursing Management
182
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
182
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
614
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175


